MedNous | Business of medical innovation

Evernow Publishing Ltd Privacy Policy. Read more.

Free featured article

BioNTech and Pfizer to develop flu vaccines

Country

Germany

Germany-based BioNTech AG is to expand its portfolio of individualised therapies beyond cancer to include infectious disease. Under a new collaboration with Pfizer Inc, the two companies will develop messenger RNA-based vaccines for the prevention of influenza.

The agreement involves an initial payment of $120 million to BioNTech plus potential development, regulatory and commercial milestones of up to up to $305 million.

Chinese valsartan banned from EU

Country

United Kingdom

China-based Zhejiang Tianyu Pharmaceutical Co Ltd has had its regulatory clearance for the supply of the active ingredient valsartan to the European market suspended following an inspection showing the presence of N-nitrosodimethylamine (NDMA), a suspected carcinogen. NDMA is classified as a probable human cardinogen based on the results of laboratory tests.

Private equity company to acquire Abzena

Country

United Kingdom

The private equity group Welsh, Carson, Anderson & Stowe (WCAS) is to acquire Abzena Plc, a service company based in Cambridge UK, that has built up an international business in antibody discovery and chemistry services with subsidiaries in two locations in the US.